Catalyst Wire Dossier Catalyst Wire Dossier

Intralymphatic immunotherapy (ILIT)

Intralymphatic immunotherapy
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Intralymphatic immunotherapy (ILIT), covering 2015-03-11 to 2016-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients [Phase 1]

See pricing